Back to Market Feed

Product Information

LINZESS 72 MCG CAPSULE is a brand product labeled by Allergan, Inc., priced at $9.0124 per EA under NDC 00456120330. Its NADAC has been published 479 times since Jun 21, 2017.

FDA first approved this application on Aug 30, 2012.

LINZESS 72 MCG CAPSULE

linaclotide
$9.0124per EA

Strength

72 ug/1

Manufacturer

Allergan, Inc.

NDC

00456120330

Classification

Brand

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LINACLOTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA202811

FDA Approved

8/30/2012

On Market Since

1/30/2017

Pharmacological Classes

Guanylate Cyclase Activators
Guanylate Cyclase-C Agonist

Price Statistics

The NADAC for LINZESS 72 MCG CAPSULE has been published 479 times since Jun 21, 2017, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.

Current price$9.0124 per EA
All-time high$18.1549 (May 14, 2025)
All-time low$9.0124 (Aug 19, 2026)
52-week high$18.1394
52-week low$9.0124
Median price$14.9289
Average price$14.6703
Largest weekly change-50.3% (Jan 14, 2026)
Weeks tracked479
Tracking sinceJun 21, 2017

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

-50.3%

3Y

-45.3%

5Y

-39.6%

All

-20.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the linaclotide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TRULANCE 3 MG TABLET
Brand
65649000330•Salix Pharmaceuticals Inc.
$18.0542
per EA

Frequently asked questions

What is the NADAC price of LINZESS 72 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LINZESS 72 MCG CAPSULE, manufactured by Allergan, Inc., is $9.0124 per EA (NDC 00456120330), effective Aug 19, 2026.

How has the price of LINZESS 72 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for LINZESS 72 MCG CAPSULE has declined 20.4%. It has been tracked across 479 weekly CMS publications since Jun 21, 2017.

What are the highest and lowest recorded NADAC prices for LINZESS 72 MCG CAPSULE?

Since Jun 21, 2017, the NADAC for LINZESS 72 MCG CAPSULE has ranged from a low of $9.0124 (Aug 19, 2026) to a high of $18.1549 (May 14, 2025), with a median of $14.9289 per EA.

Are there cheaper alternatives to LINZESS 72 MCG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of LINZESS 72 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LINZESS 72 MCG CAPSULE?

LINZESS 72 MCG CAPSULE (NDC 00456120330) is labeled by Allergan, Inc., and CMS classifies it as a brand product.